new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




  

Decode Genetics Ehf patents

Recent patent applications related to Decode Genetics Ehf. Decode Genetics Ehf is listed as an Agent/Assignee. Note: Decode Genetics Ehf may have other listings under different names/spellings. We're not affiliated with Decode Genetics Ehf, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "D" | Decode Genetics Ehf-related inventors




Date Decode Genetics Ehf patents (updated weekly) - BOOKMARK this page
11/03/16Genetic variants as markers for use in diagnosis, prognosis and treatment of eosinophilia, asthma and myocardial infarction
11/06/14Genetic variants for predicting risk of breast cancer
09/18/14Substituted benzoazole pde4 inhibitors for treating pulmonary and cardiovascular disorders
09/04/14Genetic variants on chr 11q and 6q as markers for prostate and colorectal cancer predisposition
08/14/14Genetic markers for risk management of atrial fibrillation, atrial flutter, and stroke
06/26/14Genetic variants on chr 5p12 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
03/27/14Genetic variants useful for risk assessment of thyroid cancer
03/20/14Variants predictive of risk of gout
12/19/13Genetic risk factors of sick sinus syndrome
11/07/13Genetic variants as markers for use in urinary bladder cancer risk assessment, diagnosis, prognosis and treatment
10/17/13Genetic variants useful for risk assessment of thyroid cancer
09/26/13Genetic variants as markers for use in diagnosis, prognosis and treatment of eosinophilia, asthma, and myocardial infarction
08/29/13Genetic markers for risk management of vascular disease
10/18/12Genetic variants indicative of vascular conditions
08/30/12Genetic markers associated with risk of diabetes mellitus
08/16/12Substituted benzoazole pde4 inhibitors for treating pulmonary and cardiovascular disorders
08/16/12Genetic susceptibility variants associated with cardiovascular disease
07/19/12Biaryl pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders
06/14/12Genetic variants in the tcf7l2 gene as diagnostic markers for risk of type 2 diabetes mellitus
05/17/12Genetic variants predictive of cancer risk in humans
01/26/12Genetic markers for risk management of atrial fibrillation and stroke
12/01/11Genetic variants for breast cancer risk assessment
11/24/11Genetic variants useful for risk assessment of thyroid cancer
11/03/11Genetic variants as markers for use in urinary bladder cancer risk assessment, diagnosis, prognosis and treatment
10/27/11Susceptibility variants for peripheral arterial disease and abdominal aortic aneurysm
09/22/11Genetic variants useful for risk assessment of thyroid cancer
09/01/11Genetic variants predictive of cancer risk
05/19/11Genetic variants on chr2 and chr16 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
04/21/11Susceptibility variants for lung cancer
01/27/11Genetic variants contributing to risk of prostate cancer
01/20/11Genetic variants on chr 5p12 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
08/26/10Susceptibility gene for myocardial infarction, stroke, and paod; methods of treatment
06/24/10Genetic variants as markers for use in diagnosis, prognosis and treatment of eosinophilia, asthma, and myocardial infarction
05/27/10Cancer susceptibility variants on chr8q24.21
05/13/10Genetic variants useful for risk assessments of coronary artery disease and myocardial infarction
03/18/10Genetic susceptibility variants associated with cardiovascular disease
02/25/10Genetic variants associated with periodic limb movements and restless legs syndrome
12/31/09Biaryl pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders
12/31/09Genetic markers for risk management of cardiac arrhythmia
12/24/09Variants at chr8q24.21 confer risk of cancer
11/26/09Sulfonamide peri-substituted bicyclics for occlusive artery disease
11/05/09Genetic variants in the tcf7l2 gene as diagnostic markers for risk of type 2 diabetes mellitus
09/17/09Biaryl substituted nitrogen containing heterocycle inhibitors of lta4h for treating inflammation
06/25/09Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation
05/28/09Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders
05/21/09Substituted benzoazole pde4 inhibitors for treating pulmonary and cardiovascular disorders
05/21/09Substituted benzoazole pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders
05/21/094- (or 5-) substituted catechol derivatives







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Decode Genetics Ehf in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Decode Genetics Ehf with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';